AXA S.A. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$9,589,000
-15.4%
89,521
-18.8%
0.02%
-21.9%
Q3 2021$11,332,000
-34.2%
110,221
-43.7%
0.03%
+28.0%
Q2 2021$17,222,000
+68.2%
195,786
+85.9%
0.02%
-19.4%
Q1 2021$10,241,000
-11.7%
105,331
+1.9%
0.03%
-13.9%
Q4 2020$11,593,000
+24.5%
103,373
+2.9%
0.04%
+5.9%
Q3 2020$9,314,000
-41.2%
100,473
-50.5%
0.03%
+9.7%
Q2 2020$15,828,000
+143.3%
202,930
+82.4%
0.03%
+93.8%
Q1 2020$6,506,000
-58.8%
111,236
-48.3%
0.02%
-48.4%
Q3 2019$15,808,000
-22.2%
215,150
-0.1%
0.03%
-22.5%
Q2 2019$20,326,000
+101.9%
215,472
+71.3%
0.04%
+2.6%
Q1 2019$10,069,000
+514.3%
125,790
+313.7%
0.04%
+457.1%
Q4 2018$1,639,000
-30.9%
30,4040.0%0.01%
-22.2%
Q3 2018$2,373,000
-3.9%
30,404
-21.8%
0.01%0.0%
Q2 2018$2,470,000
+138.4%
38,904
+244.3%
0.01%
+125.0%
Q1 2018$1,036,000
+7.4%
11,300
-11.7%
0.00%0.0%
Q4 2017$965,000
+45.8%
12,800
+34.7%
0.00%
+33.3%
Q3 2017$662,0009,5000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders